Methods of treating medical conditions by transvascular neuromodulation of the autonomic nervous system

• US 20060085046A1
• Filed: 09/12/2005
• Published: 04/20/2006
• Est. Priority Date: 01/20/2000
• Status: Abandoned Application

• Current Assignee: Cleveland Clinic Foundation
• Original Assignee: Cleveland Clinic Foundation
• Inventors: Ansarinia, Mehdi, Rezai, Ali
• Application Number:
  US11/222,766
• Publication Number:
  US 20060085046A1
• Time in Patent Office: Days
• US Class Current: 607/40
• CPC Class Codes: A61N 1/05 for implantation or insertion into the body, e.g. heart electrode A61N1/06 takes precedence
• CPC Class Codes: A61N 1/36017 with leads or electrodes penetrating the skin
• CPC Class Codes: A61N 1/36025 for treating a mental or cerebral condition
• CPC Class Codes: A61N 1/36071 Pain
• CPC Class Codes: A61N 1/36082 Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease

Abstract

The present invention is directed to a method for treating a gastrointestinal condition by transvascular neuromodulation of a target site of the autonomic nervous system and preferably a target site in communication with a sympathetic nerve chain. A method for treating a gastrointestinal condition via transvascular neuromodulation incorporating a closed-loop feedback system is also provided.

Claims

1. A method for treating a gastrointestinal condition comprising:

inserting a therapy delivery device into a vessel of the body;

advancing the therapy deliver device in the vessel to a point adjacent a target site of the autonomic nervous system; and

activating the therapy delivery device to deliver a therapy signal to the target site of the autonomic nervous system to treat the gastrointestinal condition.

2. The method of claim 1 wherein the target site is in communication with a sympathetic nerve chain.

3. The method of claim 1, wherein the target site is a sympathetic ganglion.

4. The method of claim 1, wherein the target site is a parasympathetic ganglion.

5. The method of claim 1, wherein the vessel is an artery.

6. The method of claim 1, wherein the vessel is a vein.

7. The method of claim 1, wherein the therapy delivery device is an electrode.

8. The method of claim 1, wherein the therapy delivery device is a drug port.

9. The method of claim 1, wherein the therapy delivery device is activated for a period of less than ten days.

10. A method of treating a gastrointestinal condition comprising:

inserting a therapy delivery device into a vessel of the body;

advancing the therapy deliver device in the vessel to a point adjacent a target site of the autonomic nervous system;

activating the therapy delivery device to deliver a therapy signal to the target site of the autonomic nervous system;

sensing a bodily activity associated with the gastrointestinal condition and generating a sensor signal; and

activating the therapy delivery device to adjust application of the therapy signal to the target site of the autonomic nervous system in response to the sensor signal to treat the gastrointestinal condition.